ALPMF (ALPMF) Stock Price & Analysis
ALPMF (ALPMF) rose 1.96% to USD 15.1 as of September 8, 2026 at 07:07 UTC, according to Nexqual real-time market data.
ALPMF last closed at USD 15.1; the session ranged USD 14.81–15 on volume of 600 shares. Market capitalization is —, with a 52-week range of USD 9.85–17.85 (PNK). Source: Nexqual, September 8, 2026 at 07:07 UTC.
Key Statistics (as of September 8, 2026 at 07:07 UTC)
| Price | USD 15.1 |
|---|---|
| Change | ▲ 1.96% (up) |
| Previous Close | USD 15.1 |
| Open | USD 15.1 |
| Day Range | USD 14.81 – 15 |
| 52-Week Range | USD 9.85 – 17.85 |
| Volume | 600 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (ALPMF)
Nexqual's technical model rates ALPMF "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 07:07 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 51.55 (neutral) |
| vs SMA50 | Above (USD 14.45) |
| MACD | 0.17 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALPMY | Astellas Pharma, Inc. | USD 15.05 | ▼ 0.46% |
| DSKYF | Daiichi Sankyo Co., Ltd. | USD 18.33 | ▼ 0.05% |
| TKPHF | Takeda Pharmaceutical Co., Ltd. | USD 36.8 | ▲ 7.54% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 21.59 | ▲ 0.09% |
| BAYZF | Bayer A.G. | USD 56.5 | ▼ 0.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:07 UTC. This page is informational and not investment advice.